Cannabis Oil to Treat Mitochondrial Disease

June 23, 2022 01:08:53
Cannabis Oil to Treat Mitochondrial Disease
MitoAction Expert Series
Cannabis Oil to Treat Mitochondrial Disease

Jun 23 2022 | 01:08:53

/

Show Notes

Join us  with Dr. Fran Kendall to get the answers to these questions and more regarding the use of medical marijuana (cannabis oil) for treatment in mitochondrial disease patients.

Georgia just signed into law the use of cannabis oil for a number of diseases, including mitochondrial disease. Several Mito families in Georgia advocated on behalf of this legislation. While 35 other states have passed similar legislation, Georgia is the first state to include mitochondrial disease in the list of disorders to be treated.

Dr. Kendall will touch on historical perspective, mechanisms of action, dosing, safety and outcome data.

About the Speaker

Dr. Kendall trained and served on the staff at Boston Children's Hospital and Harvard Medical School for a number of years. She was the previous 50% owner of a successful genetic laboratory/healthcare provider (Horizon Molecular Medicine), and has extensive experience in the diagnosis and management of children with a wide array of metabolic disorders. She brings this vast experience to her private practice, VMP, LCC, as president and founder. Dr. Kendall is a well respected pediatrician as well as biochemical geneticist, and she has authored numerous research articles on rare diseases ranging from Nieman Pick Type C and mitochondrial disease. As one of the few clinical mitochondrial disease experts, she has a long-term interest in research and clinical aspects of rare metabolic diseases.

Other Episodes

Episode

April 13, 2022 01:28:29
Episode Cover

Genetic Inheritance in Mitochondrial Disease: Fact vs. Fiction

MITO Meeting: MONTHLY INTERNATIONAL TELECONFERENCE OUTREACH Join us with Dr. Katherine Sims from Massachusetts General Hospital as we take a closer look at understanding...

Listen

Episode

March 18, 2022 00:52:51
Episode Cover

MELAS Spectrum Disorders and Sonlicromanol: Progress Update

Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion for our our March Expert Series presentation. MELAS spectrum (m.3243A>G) disorders belong to the most...

Listen

Episode 0

July 03, 2020 00:57:45
Episode Cover

Mitochondrial Replacement Therapy - Dr. Michio Hirano & Kris Engelstad - 4/21/2017

Dr. Michio Hirano, Chief of the Neuromuscular Division at Columbia University Medical Center, and Kris Engelstad MS CGC, a board-certified genetic counselor and program...

Listen